PI Pharma Insight

BNF presentation directory

Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.

Reset
Presentation Product Chemical substance Chapter Items dispensed
Minocin 50mg tablets
0501030P0BBAAAA
Minocin Minocycline hydrochloride Infections No data available
Minocycline 50mg/5ml oral liquid
0501030P0AAAFAF
Minocycline hydrochloride (Systemic) Minocycline hydrochloride Infections No data available
Monotrim 100mg tablets
0501080W0BCAAAD
Monotrim Trimethoprim Infections No data available
Monotrim 100mg/5ml solution for injection ampoules
0501080W0BCADAA
Monotrim Trimethoprim Infections No data available
Monotrim 200mg tablets
0501080W0BCABAE
Monotrim Trimethoprim Infections No data available
Monotrim 50mg/5ml oral suspension
0501080W0BCACAI
Monotrim Trimethoprim Infections No data available
Monurol 3g granules for oral solution sachets
0501070AEBCAAAD
Monurol Fosfomycin trometamol Infections No data available
Moxifloxacin 400mg/250ml infusion bags
0501120Y0AAACAC
Moxifloxacin Moxifloxacin Infections No data available
Moxifloxacin 400mg/250ml solution for infusion bottles
0501120Y0AAABAB
Moxifloxacin Moxifloxacin Infections No data available
Moxifloxacin 400mg/5ml oral solution
0501120Y0AAADAD
Moxifloxacin Moxifloxacin Infections No data available
Munuza 300mg/5ml nebuliser solution 5ml ampoules
0501040U0BHAAAG
Munuza Tobramycin Infections No data available
Mycamine 100mg powder for solution for infusion vials
0502040B0BBAAAA
Mycamine Micafungin Infections No data available
Mycamine 50mg powder for solution for infusion vials
0502040B0BBABAB
Mycamine Micafungin Infections No data available
Mycifor XL 500mg tablets
0501050B0BFAAAE
Mycifor Clarithromycin Infections No data available
Nalidixic acid 300mg/5ml oral suspension
0501120N0AAAAAA
Nalidixic acid Nalidixic acid Infections No data available
Nalidixic acid 300mg/5ml oral suspension sugar free
0501120N0AAAFAF
Nalidixic acid Nalidixic acid Infections No data available
Nalidixic acid 500mg tablets
0501120N0AAABAB
Nalidixic acid Nalidixic acid Infections No data available
National 30 day HIV post exposure prophylaxis pack
0503010AYBBAAAA
National 30 day HIV Raltegravir/Emtricitabine/Tenofovir disoproxil Infections No data available
Nebcin 20mg/2ml solution for injection vials
0501040U0BBAAAA
Nebcin Tobramycin Infections No data available
Negaban 1g powder for solution for injection vials
0501012U0BCAAAB
Negaban Temocillin sodium Infections No data available
Negram 300mg/5ml oral suspension
0501120N0BBABAF
Negram Nalidixic acid Infections No data available
Negram 500mg tablets
0501120N0BBAAAB
Negram Nalidixic acid Infections No data available
Nelfinavir 250mg tablets
0503010C0AAAAAA
Nelfinavir mesilate Nelfinavir mesilate Infections No data available
Nelfinavir 50mg/g oral powder
0503010C0AAABAB
Nelfinavir mesilate Nelfinavir mesilate Infections No data available
Neomycin 100mg/5ml oral solution
0501040N0AAAJAJ
Neomycin sulfate (Systemic) Neomycin sulfate Infections No data available

Why monitor BNF codes?

Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.

Track cost pressure

Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.

Understand demand drivers

Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.